Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis

The authors report a case of a male patient from Bacabal, MA with diffuse cutaneous leishmaniasis (DCL), for at least nine years, with 168 lesions on his body. These were tumour-like nodules with some ulceratmi. He usedpentavalent antimonial (glucantime®) and an association of gamma interferon plus...

Full description

Bibliographic Details
Main Authors: Jackson Mauricio Lopes Costa, Marta Solange C. Moraes, Ana Cristina R. Saldanha, Aldina Barral, Marcelo N. Burattini
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 1995-12-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821995000400015&lng=en&tlng=en
_version_ 1817978715578040320
author Jackson Mauricio Lopes Costa
Marta Solange C. Moraes
Ana Cristina R. Saldanha
Aldina Barral
Marcelo N. Burattini
author_facet Jackson Mauricio Lopes Costa
Marta Solange C. Moraes
Ana Cristina R. Saldanha
Aldina Barral
Marcelo N. Burattini
author_sort Jackson Mauricio Lopes Costa
collection DOAJ
description The authors report a case of a male patient from Bacabal, MA with diffuse cutaneous leishmaniasis (DCL), for at least nine years, with 168 lesions on his body. These were tumour-like nodules with some ulceratmi. He usedpentavalent antimonial (glucantime®) and an association of gamma interferon plus glucantime with improvement of the lesions but relapsed later. Recently, pentamidine isethionate (pentacarinat®) was given a dosage of 4mg/kg/weight/day on alternate days for 20 applications. After 3 months a similar course of 10 application was given 2 times. Later he developed diabetic signs with weight loss of 10kg, polydypsia, polyuria and xerostomia. The lower limbs lesions showed signs of activity. Blood glucose levels normalised and remain like this at moment. Attention is drawn to the fact that pentamidine isethionate should be used as a therapy option with care, obeyng rigorous laboratory controls including a glucose tolerance test.
first_indexed 2024-04-13T22:33:46Z
format Article
id doaj.art-bae7d0e1ffaf4fe186b0a513b336a94a
institution Directory Open Access Journal
issn 1678-9849
language English
last_indexed 2024-04-13T22:33:46Z
publishDate 1995-12-01
publisher Sociedade Brasileira de Medicina Tropical (SBMT)
record_format Article
series Revista da Sociedade Brasileira de Medicina Tropical
spelling doaj.art-bae7d0e1ffaf4fe186b0a513b336a94a2022-12-22T02:26:51ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-98491995-12-0128440540710.1590/S0037-86821995000400015S0037-86821995000400015Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasisJackson Mauricio Lopes CostaMarta Solange C. MoraesAna Cristina R. SaldanhaAldina BarralMarcelo N. BurattiniThe authors report a case of a male patient from Bacabal, MA with diffuse cutaneous leishmaniasis (DCL), for at least nine years, with 168 lesions on his body. These were tumour-like nodules with some ulceratmi. He usedpentavalent antimonial (glucantime®) and an association of gamma interferon plus glucantime with improvement of the lesions but relapsed later. Recently, pentamidine isethionate (pentacarinat®) was given a dosage of 4mg/kg/weight/day on alternate days for 20 applications. After 3 months a similar course of 10 application was given 2 times. Later he developed diabetic signs with weight loss of 10kg, polydypsia, polyuria and xerostomia. The lower limbs lesions showed signs of activity. Blood glucose levels normalised and remain like this at moment. Attention is drawn to the fact that pentamidine isethionate should be used as a therapy option with care, obeyng rigorous laboratory controls including a glucose tolerance test.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821995000400015&lng=en&tlng=enLeishmaniose cutânea difusaIsotionato de pentamidinaDiabetes mellitusEstado do Maranhão
spellingShingle Jackson Mauricio Lopes Costa
Marta Solange C. Moraes
Ana Cristina R. Saldanha
Aldina Barral
Marcelo N. Burattini
Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis
Revista da Sociedade Brasileira de Medicina Tropical
Leishmaniose cutânea difusa
Isotionato de pentamidina
Diabetes mellitus
Estado do Maranhão
title Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis
title_full Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis
title_fullStr Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis
title_full_unstemmed Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis
title_short Diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis
title_sort diabetes melutus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis
topic Leishmaniose cutânea difusa
Isotionato de pentamidina
Diabetes mellitus
Estado do Maranhão
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821995000400015&lng=en&tlng=en
work_keys_str_mv AT jacksonmauriciolopescosta diabetesmelutusassociatedwithpentamidineisethionateindiffusecutaneousleishmaniasis
AT martasolangecmoraes diabetesmelutusassociatedwithpentamidineisethionateindiffusecutaneousleishmaniasis
AT anacristinarsaldanha diabetesmelutusassociatedwithpentamidineisethionateindiffusecutaneousleishmaniasis
AT aldinabarral diabetesmelutusassociatedwithpentamidineisethionateindiffusecutaneousleishmaniasis
AT marcelonburattini diabetesmelutusassociatedwithpentamidineisethionateindiffusecutaneousleishmaniasis